These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9363867)

  • 61. Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies.
    Esteva FJ; Cheli CD; Fritsche H; Fornier M; Slamon D; Thiel RP; Luftner D; Ghani F
    Breast Cancer Res; 2005; 7(4):R436-43. PubMed ID: 15987448
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patients.
    Nagorsen D; Scheibenbogen C; Schaller G; Leigh B; Schmittel A; Letsch A; Thiel E; Keilholz U
    Int J Cancer; 2003 Jun; 105(2):221-5. PubMed ID: 12673683
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HER-2/neu overexpression in breast cancer: an immunohistochemical study including correlations with clinicopathologic parameters, p53 oncoprotein and cathepsin-D.
    Korkolis D; Ardavanis A; Yotis J; Kyroudi A; Gorgoulis V; Kittas C
    Anticancer Res; 2001; 21(3C):2207-12. PubMed ID: 11501848
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cancer vaccines targeting the HER2/neu oncogenic protein.
    Disis ML; Schiffman K
    Semin Oncol; 2001 Dec; 28(6 Suppl 18):12-20. PubMed ID: 11774201
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical utility of serum HER-2/neu testing on the Bayer Immuno 1 automated system in breast cancer.
    Cook GB; Neaman IE; Goldblatt JL; Cambetas DR; Hussain M; Lüftner D; Yeung KK; Chan DW; Schwartz MK; Allard WJ
    Anticancer Res; 2001; 21(2B):1465-70. PubMed ID: 11396233
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human HER-2/neu protein immunization circumvents tolerance to rat neu: a vaccine strategy for 'self' tumour antigens.
    Disis ML; Shiota FM; Cheever MA
    Immunology; 1998 Feb; 93(2):192-9. PubMed ID: 9616368
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quantitative assessment of HER-2/neu protein concentration in breast cancer by enzyme-linked immunosorbent assay.
    Müller V; Thomssen C; Karakas C; Eustermann I; Ramirez Porras J; Coith C; Berger J; Löning T; Jänicke F; Pantel K
    Int J Biol Markers; 2003; 18(1):13-20. PubMed ID: 12699058
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera.
    Lu H; Ladd J; Feng Z; Wu M; Goodell V; Pitteri SJ; Li CI; Prentice R; Hanash SM; Disis ML
    Cancer Prev Res (Phila); 2012 Aug; 5(8):1036-43. PubMed ID: 22715141
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure.
    Kmieciak M; Payne KK; Idowu MO; Grimes MM; Graham L; Ascierto ML; Wang E; Wang XY; Bear HD; Manjili MH
    J Transl Med; 2011 Mar; 9():35. PubMed ID: 21453513
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Binding of circulating anti-MUC1 antibody and serum MUC1 antigen in stage IV breast cancer.
    Tang Y; Cui X; Xiao H; Qi S; Hu X; Yu Q; Shi G; Zhang X; Gu J; Yu Y; Wang L; Li Y
    Mol Med Rep; 2017 May; 15(5):2659-2664. PubMed ID: 28447743
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Automated assay for HER-2/neu in serum.
    Payne RC; Allard JW; Anderson-Mauser L; Humphreys JD; Tenney DY; Morris DL
    Clin Chem; 2000 Feb; 46(2):175-82. PubMed ID: 10657373
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multipanel assay of 17 tumor-associated antibodies for serological detection of stage 0/I breast cancer.
    Sumazaki M; Ogata H; Nabeya Y; Kuwajima A; Hiwasa T; Shimada H
    Cancer Sci; 2021 May; 112(5):1955-1962. PubMed ID: 33605508
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Monoclonal and polyclonal humoral immune response to EC HER-2/NEU peptides with low similarity to the host's proteome.
    Mittelman A; Lucchese A; Sinha AA; Kanduc D
    Int J Cancer; 2002 Apr; 98(5):741-7. PubMed ID: 11920645
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Femtomolar electroanalysis of a breast cancer biomarker HER-2/neu protein in human serum by the cellulase-linked sandwich assay on magnetic beads.
    Malecka K; Pankratov D; Ferapontova EE
    Anal Chim Acta; 2019 Oct; 1077():140-149. PubMed ID: 31307703
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The neu-oncogene product in serum and tissue of patients with breast carcinoma.
    Kath R; Höffken K; Otte C; Metz K; Scheulen ME; Hülskamp F; Seeber S
    Ann Oncol; 1993 Aug; 4(7):585-90. PubMed ID: 8103351
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Soluble fragment of HER2/neu receptor in the serum of patients with breast cancer with different levels of this protein expression in the tumor.
    Kushlinskii NE; Shirokii VP; Gershtein ES; Yermilova VD; Chemeris GY; Letyagin VP
    Bull Exp Biol Med; 2007 Apr; 143(4):449-51. PubMed ID: 18214297
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of humoral immunity and calreticulin overexpression on postoperative course in breast cancer.
    Erić A; Juranić Z; Milovanović Z; Marković I; Inić M; Stanojević-Bakić N; Vojinović-Golubović V
    Pathol Oncol Res; 2009 Mar; 15(1):89-90. PubMed ID: 18925427
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum HER-2/neu: a new predictive marker.
    Voss A; Neumann R
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):584-5. PubMed ID: 12503824
    [No Abstract]   [Full Text] [Related]  

  • 79. Immunity to the HER-2/neu oncogenic protein.
    Disis ML; Bernhard H; Gralow JR; Hand SL; Emery SR; Calenoff E; Cheever MA
    Ciba Found Symp; 1994; 187():198-207; discussion 207-11. PubMed ID: 7540970
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of the circulating fraction of the HER-2/neu oncogene in patients with cervical cancer.
    Contreras DN; Cobos E; Lox CD
    Eur J Gynaecol Oncol; 2002; 23(6):491-5. PubMed ID: 12556089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.